Market Place
Sourcing Support
Neurogene Appoints Christy Shafer CCO & Christine Mikail to Board
20 Apr 2026 //
PHARMIWEB
Neurogene Inducement Grants Under Nasdaq LR 5635(c)(4)
05 Sep 2025 //
BUSINESSWIRE
Neurogene`s Q2 2025 Financial Results and Recent Updates
11 Aug 2025 //
BUSINESSWIRE
Neurogene Announces Inducement Grant Under Nasdaq Rule 5635(c)(4)
08 Aug 2025 //
BUSINESSWIRE
Neurogene grants inducements under Nasdaq Listing Rule 5635(c)(4)
03 Jul 2025 //
BUSINESSWIRE
Neurogene Announces Inducement Grants Under Nasdaq Rule 5635(c)(4
06 Jun 2025 //
BUSINESSWIRE
Neurogene Reports Q1 2025 Financial Results and Recent Updates
09 May 2025 //
BUSINESSWIRE
Neurogene Announces Inducement Grants Under Nasdaq Rule
08 May 2025 //
BUSINESSWIRE
Neurogene Reports 2024 Financial Results and Recent Updates
24 Mar 2025 //
BUSINESSWIRE
Neurogene to Participate in Upcoming Conferences
24 Feb 2025 //
BUSINESSWIRE
Neurogene Reports Q3 2024 Financial Results & Updates
18 Nov 2024 //
BUSINESSWIRE
Voyager Therapeutics Announces Q3 2024 Conference Call & Webcast
05 Nov 2024 //
GLOBENEWSWIRE
Neurogene to Participate in BMO Genetic Medicines Summit
02 Jul 2024 //
BUSINESSWIRE
Neurogene Announces Addition to Russell 3000® Index
01 Jul 2024 //
BUSINESSWIRE
Neurogene to Participate in Upcoming Conferences
05 Jun 2024 //
BUSINESSWIRE
Neurogene Q1 2024 Financials, Recent Updates
10 May 2024 //
BUSINESSWIRE
Neurogene Reports Fourth Quarter and Full Year 2023 Financial Results
18 Mar 2024 //
BUSINESSWIRE
Neurogene Announces Appointment of Julie Jordan, M.D., as Chief Medical Officer
16 Jan 2024 //
BUSINESSWIRE
Neurogene Announces Business Update and 2024 Outlook
05 Jan 2024 //
BUSINESSWIRE
Neurogene Announces Closing of Merger with Neoleukin Therapeutics
19 Dec 2023 //
BUSINESSWIRE
FDA clears Neurogene`s IND for NGN-101 Gene Therapy to Treat CLN5 Batten Disease
14 Sep 2021 //
BIOSPACE
Neurogene Announces EMA Grants Orphan Drug Designation to CLN5
29 Jun 2021 //
BUSINESSWIRE
Neurogene’s AAV Biodistribution Study Shows Route of Administration Essential
11 May 2021 //
BUSINESSWIRE
Neurogene and University of Edinburgh Announce Research Collaboration
20 Jan 2021 //
BUSINESSWIRE
Neurogene and University of Edinburgh Announce Research Collaboration
20 Jan 2021 //
BUSINESSWIRE
Neurogene and University of Edinburgh Announce Research Collaboration
18 Jan 2021 //
BUSINESSWIRE
Neurogene Closes $115 Million Series B Financing
15 Dec 2020 //
BUSINESSWIRE
Neurogene Announces EMA Grants Orphan Drug Designation Gene Therapy
03 Dec 2020 //
BUSINESSWIRE
Neurogene Appoints Industry Veteran Robert A. Baffi, Ph.D. to Board of Directors
16 Sep 2020 //
BUSINESSWIRE
